n/a
Article Publish Status: FREE
Abstract Title:

Virtual screening of phytoconstituents from miracle herbtargeting nucleocapsid protein and papain-like protease of SARS-CoV-2 for COVID-19 treatment.

Abstract Source:

J Biomol Struct Dyn. 2020 Dec 8:1-21. Epub 2020 Dec 8. PMID: 33289456

Abstract Author(s):

Sahabjada Siddiqui, Shivbrat Upadhyay, Rumana Ahmad, Anamika Gupta, Aditi Srivastava, Anchal Trivedi, Ishrat Husain, Bilal Ahmad, Maqusood Ahamed, Mohsin Ali Khan

Article Affiliation:

Sahabjada Siddiqui

Abstract:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel etiological agent of coronavirus disease 2019 (COVID-19)., commonly known as black seed or black cumin, has been a historical and traditional plant since thousands of years. Based on their therapeutic efficacy, the chief components of terpenoids and flavonoids were selected fromseeds and seed oil. This study was designed to check the antiviral efficacy ofmain phytoconstituents against five potential targets of SARS-CoV-2 usingstructure-based virtual screening approach. Out of twenty five phytocomponents, ten components showed best binding affinity against two viral proteinsN-terminal RNA binding domain (NRBD; PDB ID: 6M3M) of nucleocapsid protein and papain-like protease (PL-; PDB ID: 6W9C) of SARS-CoV-2 using AutoDock 4.2.6, AutoDock Vina and iGEMDOCK. PASS analyses of all ten phytocomponents using Lipinski's Rule of five showed promising results. Further, druglikeness and toxicity assessment using OSIRIS Data Warrior v5.2.1 software exhibited the feasibility of phytocomponents as drug candidates with no predicted toxicity. Molecular dynamics simulation study of NRBD of SARS-CoV-2 nucleocapsid protein-alpha-spinasterol complex and PL--cycloeucalenol complex displayed strong stability at 300 K. Both these complexes exhibited constant root mean square deviation (RMSDs) of protein side chains and Cα atoms throughout the simulation run time. Interestingly, PL-and NRBD are key proteins in viral replication, host cell immune evasion and viral assembly. Thus, NRBD and PL-have the potential to serve as therapeutic targets forphytoconstituents in drug discovery process against COVID-19.

Study Type : In Vitro Study

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.